Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies

Figure 2

One-year mortality rate of anti-Jo-1 and anti-MDA-5 patients.